IDEAYA Biosciences, Inc.
NASDAQIDEAYA Biosciences heads into the week after reporting earnings with the Street still constructive but quietly trimming targets, while short sellers who spent June building positions have spent July unwinding them. The most striking shift in IDYA's positioning is the magnitude of short covering that has occurred over the past five weeks. Short interest peaked above 11.2 million…
Snapshot as of 25 Aug 2026
IDEAYA Biosciences heads into the week after reporting earnings with the Street still constructive but quietly trimming targets, while short sellers who spent June building positions have spent July unwinding them. The…
IDEAYA Biosciences reports Monday after the close with short sellers pulling back from recent highs — yet the dominant shift heading into the print is a sharp rotation toward bullish options positioning. The options…
IDEAYA Biosciences heads into its May 6 earnings release with a noteworthy split between short sellers building exposure and options traders positioned for upside rather than protection. Short interest has climbed…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for IDYA — free to start on ORTEX.
Sign up for free →Open IDYA on ORTEX